Rups Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -22.06%
(FY 2023)
- Profit -14.50%
(FY 2023)
- Ebitda -71.81%
(FY 2023)
- Net Worth 49.46%
(FY 2023)
- Total Assets 17.94%
(FY 2023)
About Rups Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Kumar, Seema Rani, Tushar Aggarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U29220DL2007PTC161311
- Company No.
161311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rups Lifesciences Private Limited offer?
Rups Lifesciences Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Laboratory Consumables.
Who are the key members and board of directors at Rups Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rhythm Aggarwal  | Director | 08-Jun-2020 | Current |
| Mukesh Kumar | Director | 11-Nov-2009 | Current |
| Seema Rani | Director | 01-Jan-2013 | Current |
| Tushar Aggarwal | Director | 08-Jun-2020 | Current |
Financial Performance of Rups Lifesciences.
Rups Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.06% decrease. The company also saw a substantial fall in profitability, with a 14.5% decrease in profit. The company's net worth Soared by an impressive increase of 49.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rups Lifesciences?
In 2023, Rups Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rups Lifesciences?
Unlock and access historical data on people associated with Rups Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rups Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rups Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
